ZA200707359B - Inhibitors of neurotrypsin and determination thereof - Google Patents

Inhibitors of neurotrypsin and determination thereof

Info

Publication number
ZA200707359B
ZA200707359B ZA200707359A ZA200707359A ZA200707359B ZA 200707359 B ZA200707359 B ZA 200707359B ZA 200707359 A ZA200707359 A ZA 200707359A ZA 200707359 A ZA200707359 A ZA 200707359A ZA 200707359 B ZA200707359 B ZA 200707359B
Authority
ZA
South Africa
Prior art keywords
neurotrypsin
inhibitors
determination
Prior art date
Application number
ZA200707359A
Other languages
English (en)
Inventor
Sonderegger Peter
Marc F Bolliger
Kunz Beat
Reif Raymond
Hettwer Stefan
Dreier Birgit
Luescher Daniel
Sales Susanne
Original Assignee
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Zuerich filed Critical Univ Zuerich
Publication of ZA200707359B publication Critical patent/ZA200707359B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/64—X and Y being nitrogen atoms, e.g. N-sulfonylguanidine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/976—Trypsin; Chymotrypsin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA200707359A 2005-03-30 2007-08-29 Inhibitors of neurotrypsin and determination thereof ZA200707359B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102481 2005-03-30

Publications (1)

Publication Number Publication Date
ZA200707359B true ZA200707359B (en) 2009-08-26

Family

ID=34939082

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707359A ZA200707359B (en) 2005-03-30 2007-08-29 Inhibitors of neurotrypsin and determination thereof

Country Status (15)

Country Link
US (1) US7897364B2 (xx)
EP (1) EP1868989A2 (xx)
JP (1) JP4920675B2 (xx)
KR (1) KR20070116932A (xx)
CN (1) CN101193858B (xx)
AU (1) AU2006228150B2 (xx)
BR (1) BRPI0609654A2 (xx)
CA (1) CA2600791A1 (xx)
IL (1) IL186120A (xx)
MX (1) MX2007011961A (xx)
NO (1) NO20075461L (xx)
NZ (1) NZ562796A (xx)
RU (1) RU2424228C2 (xx)
WO (1) WO2006103261A2 (xx)
ZA (1) ZA200707359B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008074813A2 (en) * 2006-12-21 2008-06-26 Neurotune Ag Optiogenin for the treatment of neural diseases
DK1990420T3 (da) * 2007-05-10 2010-11-15 Neurotune Ag Fremgangsmåde til detektering af in vivo-aktiviteten af neurotrypsin, anvendelse af fremgangsmåden og anvendelse af det C-terminale 22-kDa-fragment af agrin som biomarkør ved diagnose og overvågning af neurotrypsin-relaterede forstyrrelser
EP2295068A1 (en) * 2009-09-04 2011-03-16 Neurotune AG Modified agrin-fragment capable of restoring muscle strength for use as a medicament
US20130245064A1 (en) 2010-11-01 2013-09-19 Shaheen Ahmed Novel neurotrypsin inhibitors
WO2012059442A2 (en) 2010-11-01 2012-05-10 Neurotune Ag Neurotrypsin inhibitors
EP2631657A1 (en) * 2012-02-25 2013-08-28 Neurotune AG Immunoassay for the detection of the 22kDa C-terminal fragment (CAF) of agrin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH692507A5 (de) 1997-04-26 2002-07-15 Peter Prof Dr Sonderegger Neurotrypsin als aktive Verbindung in einem Medikament.
DE19919634C2 (de) 1999-04-30 2001-06-07 Aventis Pharma Gmbh Test zur Bestimmung der Integrität komplexer Phospholipid/Lipid-Strukturen mit Hilfe synthetischer fluoreszenz-markierter Acylglyceride und dessen Anwendung zur Bestimmung der Aktivität von Lipasen
DE10247478A1 (de) 2002-10-11 2004-06-24 Bioagency Ag Verfahren zur Bestimmung der enzymatischen Aktivität von Proteinen

Also Published As

Publication number Publication date
BRPI0609654A2 (pt) 2010-04-20
AU2006228150A1 (en) 2006-10-05
CA2600791A1 (en) 2006-10-05
WO2006103261A2 (en) 2006-10-05
IL186120A (en) 2012-08-30
RU2007139754A (ru) 2009-05-10
CN101193858A (zh) 2008-06-04
EP1868989A2 (en) 2007-12-26
JP4920675B2 (ja) 2012-04-18
MX2007011961A (es) 2008-03-14
IL186120A0 (en) 2008-01-20
AU2006228150B2 (en) 2011-09-29
WO2006103261A3 (en) 2007-02-22
US20090170950A1 (en) 2009-07-02
JP2008538178A (ja) 2008-10-16
KR20070116932A (ko) 2007-12-11
NZ562796A (en) 2010-02-26
NO20075461L (no) 2007-11-20
WO2006103261A9 (en) 2010-05-27
CN101193858B (zh) 2012-01-04
RU2424228C2 (ru) 2011-07-20
US7897364B2 (en) 2011-03-01

Similar Documents

Publication Publication Date Title
EP1812049A4 (en) KALLIKREIN INHIBITORS AND USES THEREOF
SI1848718T1 (sl) Inhibitorji E1 aktivacijskih enzimov
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
EP1940787A4 (en) NOVEL IDO INHIBITORS AND METHODS OF USE
EP1756092A4 (en) NEW INHIBITORS OF RHO-KINASEN
IL189668A0 (en) Inhibitors of serine proteases
ZA200801114B (en) Inhibitors of serine proteases
EP1742627A4 (en) PDE4B HEMMER AND ITS USE
EP1931205A4 (en) TRANSGLUTAMINASE INHIBITORS AND METHOD OF USE THEREOF
IL192134A0 (en) Soft protease inhibitors and pro-soft forms thereof
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
ZA200704888B (en) Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
EP1929297A4 (en) BIOMARKERS FOR MULTIPLE SCLEROSIS AND USE METHOD THEREFOR
HK1122988A1 (en) Proteasome inhibitors and uses thereof
ZA200606176B (en) Novel Hydroxy-6-heteroarylphenanthridines and their as PDE4 inhibitors
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
EP1799682A4 (en) REVERSIBLE INHIBITORS OF S-ADENOSYL-L-HOMOCYSTEIN HYDROLASE AND USES THEREOF
EP1877424A4 (en) INHIBITORS OF PROTEIN KINASES AND USES THEREOF
IL181819A0 (en) Enzyme inhibitors and uses thereof
ZA200804681B (en) Inhibitors of C-Met and uses thereof
IL186120A0 (en) Inhibitors of neurotrypsin and determination thereof
EP1883404A4 (en) P38 INHIBITORS AND METHODS OF USE
IL177647A0 (en) Use of enzyme
EP1940458A4 (en) COMPOSITIONS AND METHODS OF INHIBITING GRANZYME B